Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Vezzoli

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|November 16, 2017
The efficacy of extrafine beclomethasone dipropionate-formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD studyDave Singh, Stefano Vezzoli, Stefano Petruzzelli, et al.
Journal of Biopharmaceutical Statistics|December 9, 2024
Investigating the impact of data monitoring committee recommendations on the probability of trial successLuca Rondano, Gaëlle Saint-Hilary, Mauro Gasparini, et al.
Pulmonary Pharmacology & Therapeutics|August 5, 2014
Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trialFrank Kanniess, Mario Scuri, Stefano Vezzoli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMADave Singh, Leonardo M Fabbri, Stefano Vezzoli, et al.
The European Respiratory Journal|April 20, 2019
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbationsAlberto Papi, Stefano Petruzzelli, Stefano Vezzoli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 27, 2017
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 studyDave Singh, Mario Scuri, Sara Collarini, et al.
Nanoscale|January 4, 2023
Purifying single photon emission from giant shell CdSe/CdS quantum dots at room temperatureSergii Morozov, Stefano Vezzoli, Alina Myslovska, et al.
Nano Letters|February 22, 2019
Nanoscale Design of the Local Density of Optical StatesSandro Mignuzzi, Stefano Vezzoli, Simon A R Horsley, et al.
Scientific Reports|March 3, 2018
Towards spontaneous parametric down conversion from monolayer MoS<sub>2</sub>Hatef Dinparasti Saleh, Stefano Vezzoli, Lucia Caspani, et al.
The European Respiratory Journal|September 14, 2018
Inhaled corticosteroid containing combinations and mortality in COPDJørgen Vestbo, Leonardo Fabbri, Alberto Papi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Chronic Obstructive Pulmonary Disease|November 16, 2017
The efficacy of extrafine beclomethasone dipropionate-formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD studyDave Singh, Stefano Vezzoli, Stefano Petruzzelli, et al.
Journal of Biopharmaceutical Statistics|December 9, 2024
Investigating the impact of data monitoring committee recommendations on the probability of trial successLuca Rondano, Gaëlle Saint-Hilary, Mauro Gasparini, et al.
Pulmonary Pharmacology & Therapeutics|August 5, 2014
Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trialFrank Kanniess, Mario Scuri, Stefano Vezzoli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMADave Singh, Leonardo M Fabbri, Stefano Vezzoli, et al.
The European Respiratory Journal|April 20, 2019
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbationsAlberto Papi, Stefano Petruzzelli, Stefano Vezzoli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 27, 2017
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 studyDave Singh, Mario Scuri, Sara Collarini, et al.
Nanoscale|January 4, 2023
Purifying single photon emission from giant shell CdSe/CdS quantum dots at room temperatureSergii Morozov, Stefano Vezzoli, Alina Myslovska, et al.
Nano Letters|February 22, 2019
Nanoscale Design of the Local Density of Optical StatesSandro Mignuzzi, Stefano Vezzoli, Simon A R Horsley, et al.
Scientific Reports|March 3, 2018
Towards spontaneous parametric down conversion from monolayer MoS<sub>2</sub>Hatef Dinparasti Saleh, Stefano Vezzoli, Lucia Caspani, et al.
The European Respiratory Journal|September 14, 2018
Inhaled corticosteroid containing combinations and mortality in COPDJørgen Vestbo, Leonardo Fabbri, Alberto Papi, et al.
Pageof 3